55
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6928 |
Pantoprazole
SKF96022,泮托拉唑,BY1023 |
Apoptosis; Proton pump; Autophagy | Apoptosis; Autophagy; Membrane transporter/Ion channel |
Pantoprazole (BY1023) 是一种质子泵抑制剂,用于短期治疗由胃食管反流病引起的食管糜烂和溃疡。它联合阿霉素可显著增加肿瘤生长延迟。它是一种取代的苯并咪唑,是H+/K+-ATPase 抑制剂,可改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。 | |||
T0161 |
Pantoprazole Sodium Hydrate
SKF96022 sodium hydrate,泮托拉唑钠水合物,BY1023 (sodium hydrate),SKF96022 (sodium hydrate) |
Apoptosis; Potassium Channel; Proton pump; Autophagy | Apoptosis; Autophagy; Membrane transporter/Ion channel |
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) 是一种具有口服活性的质子泵抑制剂。它是取代的苯并咪唑,是H+/K+-ATPase 抑制剂。它可改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。它联合阿霉素可显著增加肿瘤生长延迟。 | |||
T6929 |
Pantoprazole sodium
Pantecta,泮托拉唑钠盐,SKF96022 sodium,SKF96022 (sodium),BY1023 (sodium),泮托拉唑钠,BY-1023 sodium,Pantoloc |
Apoptosis; Others; Proton pump; HIF; Autophagy | Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; Membrane transporter/Ion channel; Others |
Pantoprazole sodium (Pantecta) 是一种具有口服活性的质子泵抑制剂,是一种取代的苯并咪唑,是H+/K+-ATPase 抑制剂,IC50为 6.8 μM。它可以改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。它联合阿霉素可显著增加肿瘤生长延迟。 | |||
T17030 |
Tegoprazan
|
ATPase; Proton pump | Membrane transporter/Ion channel |
Tegoprazan 是一种口服有效的、高选择性胃 H+/K+-ATP 酶 (H+/K+-ATPase) 抑制剂,能够控制胃酸分泌和运动,在体外检测的对猪、犬、人的 H+/K+-ATP 酶的 IC50为0.29-0.52 μM。 | |||
T2404 |
Vonoprazan fumarate
富马酸沃诺拉赞,TAK-438 |
ATPase | Membrane transporter/Ion channel |
Vonoprazan fumarate (TAK-438) 是一种新型 P-CAB(钾竞争性酸阻滞剂),可可逆地抑制 H+/K+、ATP 酶。 | |||
T21254 |
Vonoprazan Fumarate
TAK-438,TAK 438,Vonoprazan Fumurate,TAK438,富马酸沃诺拉赞 |
Proton pump | Membrane transporter/Ion channel |
Vonoprazan Fumarate (TAK438) 是质子泵的有效抑制剂,是口服有效的高效钾竞争性酸阻断剂,具有抗分泌活性。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50为 19 nM。它被开发用于研究酸相关疾病,如消化性溃疡和胃食管反流病。 | |||
T16865 |
SCH28080
|
ATPase; Proton pump | Membrane transporter/Ion channel |
SCH28080 是一种可逆且具有 K+ 竞争性的胃 H+/K+-ATP 酶 (H+/K+-ATPase) 抑制剂,IC50 值为 20 nM (家兔微粒体膜)。SCH28080 在体内是有效的酸分泌抑制剂,具有抗溃疡活性、抗分泌和细胞保护活性。 | |||
T28136 |
NC-1300-B
NC1300B,NC 1300 B |
ATPase | Membrane transporter/Ion channel |
NC-1300-B 抑制 H(+)-K(+)-ATP 酶,可用于研究胃溃疡。 | |||
T10435 |
Linaprazan
利那拉生,AZD0865 |
Potassium Channel | Membrane transporter/Ion channel |
Linaprazan (AZD0865) 通过K+竞争抑制胃中的H+,K+ -ATPase. (IC 50: 1.0 ± 0.2 μM)。Linaprazan 对酸有很强的抑制作用。 | |||
T9553 |
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid
|
Others | Others |
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-car 是一种 H+/K+ ATPase 抑制剂,IC50=0.38μM。 | |||
T27812 |
Leminoprazole
|
ATPase | Membrane transporter/Ion channel |
Leminoprazole 是一种可口服的 H+,K(+)-ATPase 抑制剂,可保护胃黏膜细胞免受各种细胞损伤,可用于治疗胃溃疡。 | |||
T19826 |
Rabeprazole
LY307640 |
Potassium Channel; STAT | JAK/STAT signaling; Membrane transporter/Ion channel; Stem Cells |
Rabeprazole (LY307640) 是一种 H+/K+-ATPase 抑制剂,通过靶向 STAT3 介导的糖酵解来抑制胃上皮细胞中的细胞增殖,可用于研究胃溃疡。 | |||
T1651 |
Rabeprazole sodium
Dexrabeprazole Sodium,LY307640 sodium,Habeprazole Sodium,雷贝拉唑钠,Rebeprazole sodium,Aciphex Sodium |
Apoptosis; Proton pump | Apoptosis; Membrane transporter/Ion channel |
Rabeprazole sodium (Habeprazole Sodium) 是一种质子泵抑制剂,不可逆地抑制胃 H+/K+-ATPase,可研究胃溃疡和胃食管反流。它诱导细胞凋亡,也抑制尿苷核苷核糖水解酶 ,IC50为 0.3 μM。 | |||
T20714 |
Levolansoprazole
左旋兰索拉唑,(S)-Lansoprazole,(-)-Lansoprazole |
Proton pump | Membrane transporter/Ion channel |
Levolansoprazole ((S)-Lansoprazole) 是一种质子泵抑制剂,不可逆地抑制壁细胞中 H+/K+ 刺激的 ATPase 泵 (IC50: 5.2 µM)。它还抑制分离的犬壁细胞中的酸形成(IC50:82 µM)。 (R)-和 (S)-兰索拉唑均具有药理活性,具有相似的效力。 | |||
T1756 |
Ilaprazole sodium
IY-81149 sodium,艾普拉唑钠 |
Proton pump; TOPK | MAPK; Membrane transporter/Ion channel |
Ilaprazole sodium (IY-81149 sodium) 是一种具有口服活性质子泵抑制剂,以剂量依赖性方式不可逆地抑制 H+/K+-ATPase,在兔壁细胞制剂中的 IC50为 6 μM。它也是一种有效的 T 细胞起源蛋白激酶(TOPK)抑制剂,用于胃溃疡的研究。 | |||
T0674 |
Lansoprazole
兰索拉唑,A-65006,AG-1749 |
Proton pump; Phospholipase; Antibacterial | Membrane transporter/Ion channel; Metabolism; Microbiology/Virology |
Lansoprazole (A-65006) 是一种可抑制胃酸生成的质子泵抑制剂。它是中性鞘磷脂酶的外泌体抑制剂。 | |||
T8388 |
Vonoprazan
TAK-438 (free base),沃诺拉赞 |
Proton pump | Membrane transporter/Ion channel |
Vonoprazan (TAK-438 (free base)) 是一种质子泵抑制剂,是口服活性钾竞争性酸阻断剂,有抗分泌作用。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50值为 19 nM。它可用于研究胃酸相关疾病。 | |||
T1756L |
Ilaprazole
IY81149,艾普拉唑,IY 81149,IY-81149 |
Proton pump; TOPK | MAPK; Membrane transporter/Ion channel |
Ilaprazole (IY-81149) 是一种具有口服活性质子泵抑制剂,以剂量依赖性方式不可逆地抑制H+/K+-ATPase,在兔壁细胞制剂中的IC50为 6 μM。它也是一种有效的T 细胞起源蛋白激酶(TOPK)抑制剂,用于胃溃疡的研究。 | |||
T10221 |
Abeprazan hydrochloride
DWP14012 hydrochloride,Fexuprazan hydrochloride |
Proton pump | Membrane transporter/Ion channel |
Abeprazan hydrochloride (Fexuprazan hydrochloride) 是一种有效的、可逆的、具有口服活性的potassium-competitive acid 阻滞剂,通过竞争性的与钾离子结合抑制 H+,K+- ATPase,而无需酸激活。Abeprazan hydrochloride 是一种质子泵抑制剂(PPI),通过减少胃酸的产生而起作用,可用于治疗胃酸相关疾病,如胃食管反流病(GERD)和消化性溃疡。 | |||
T2686L |
Esomeprazole Sodium
埃索美拉唑钠,(S)-Omeprazole sodium |
ATPase; Proton pump | Membrane transporter/Ion channel |
Esomeprazole Sodium ((S)-Omeprazole sodium) 是一种口服有效的活性质子泵抑制剂。Esomeprazole sodium 通过抑制胃壁细胞中的 H+, K+-ATPase 来降低酸分泌,在胃食管反流疾病中有研究价值。Esomeprazole 是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T2686 |
Esomeprazole Magnesium
(S)-Omeprazole magnesium,NEXIUM,埃索美拉唑镁,(-)-Omeprazole magnesium |
ATPase; Proton pump | Membrane transporter/Ion channel |
Esomeprazole Magnesium (NEXIUM) 是一种口服有效的 H+, K+-ATPase 抑制剂,在上消化道疾病和胃食管反流疾病中具有研究价值。Esomeprazole magnesium 是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T2093 |
PF 03716556
PF-3716556 |
ATPase | Membrane transporter/Ion channel |
PF 03716556 (PF-3716556) 是一种有效且特异性的 P-CAB(钾竞争性酸阻滞剂),用于治疗胃食管反流病。 | |||
T0825 |
Ebselen
SPI-1005,PZ-51,依布硒,CCG-39161 |
Phosphatase; Virus Protease; Calcium Channel; COX; HIV Protease | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Ebselen (CCG-39161) 是一种谷胱甘肽过氧化物酶模拟物,是电压依赖性钙通道阻断剂。它抑制Mpro 和COVID-19病毒,是HIV-1衣壳 CTD 二聚化的抑制剂,具有抗炎、抗癌和抗氧化活性。 | |||
T8386 |
Esomeprazole Magnesium trihydrate
埃索美拉唑镁三水合物,埃索美拉唑镁(三水),(S)-Omeprazole magnesium trihydrate |
Proton pump | Membrane transporter/Ion channel |
Esomeprazole Magnesium trihydrate ((S)-Omeprazole magnesium trihydrate) 是一种口服有效的H+, K+-ATPase 抑制剂,在上消化道疾病和胃食管反流疾病的研究中具有价值。它是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T1734 |
Rabeprazole Sulfide
雷贝拉唑相关物质E,Rabeprazole Related Compound E |
Proton pump; Antibacterial | Membrane transporter/Ion channel; Microbiology/Virology |
Rabeprazole Sulfide (Rabeprazole Related Compound E) 是 Rabeprazole 的活性代谢产物。Rabeprazole 是一种质子泵抑制剂类的抗溃疡药物,有效抑制幽门螺旋杆菌的活性,可通过与胃壁细胞中的(H+/K+)-ATPase 相互作用来抑制胃酸分泌,可研究各种消化系统疾病。 | |||
T12471 | Picoprazole | Others | Others |
Picoprazole is a specific H+/K+-ATPase inhibitor (IC50 of 3.1±0.4 μM). | |||
T12822 | S3337 | Others | Others |
S3337 is an inhibitor of H+, K+-ATPase | |||
T16894 |
SKF96067
|
Others | Others |
SKF96067 is a reversible gastric H+/K+-ATPase inhibitor. | |||
T12977 |
Soraprazan
BYK61359 |
Others | Others |
Soraprazan is a reversible, and fast-acting gastric H+/K+ ATPase inhibitor. | |||
T23685 |
AHR-9294
|
||
AHR-9294 is a novel inhibitor of H, K-ATPase. It also antagonizes gastric HCl secretion in vivo. | |||
T30250 |
AZD0865
AZD-0865,AZD 0865 |
||
AZD0865 is an effective drug that inhibits gastric H(+), K(+) -ATPase activity and acid formation in vitro, with rapid onset. | |||
T69801 | AU-461 | ||
AU-461 is a gastric H(+)/K(+) ATPase inhibitor which acts as an anti-ulcer agent. | |||
T28563 |
Ro 18-5364
Ro-18-5364,Ro 185364 |
||
Ro 18-5364 is a potent inhibitor of the gastric (H+ + K+)-ATPase with an apparent Ki of 0.1 μM at pH 6. | |||
T76374 |
SPAI-1
|
||
SPAI-1,特异性单价阳离子ATP酶抑制剂,源自猪十二指肠。能体外抑制Na+,K+-ATP酶和H+,K+-ATP酶,同时刺激Mg2+-ATP酶。 | |||
T26450 |
A 80915A
A80915A,A-80915A |
||
A 80915A is A semi-naphthoquinone antibiotic from Streptomyces aculeolatus. It is a potent inhibitor of gastric (H(+)-K+)-ATPase. Inhibition by A80915A is dependent on the conformation of gastric (H(+)-K+)-ATPase, potassium slows the rate of inhibition by | |||
T27092 |
CS-526
R-105266,R 105266,R105266 |
||
CS-526 is a proton pump inhibitor. The inhibitory mechanism of CS-526 on H+,K+-ATPase was a competitive antagonism to the K+ binding site of H+,K+-ATPase, and it was also a reversible inhibition. CS-526 has a potent antisecretory effect on gastric acid se | |||
T28609 |
Rohitukine
NSC623611,NSC-623611,NSC 623611 |
||
Rohitukine is an anti-cancer agent. It modulates apoptosis pathways through gastrin antagonism and H(+) K (+)-ATPase inhibition. Rohitukine ia an antiadipogenic, antidyslipidemic, gastroprotective, antifertility, and antileishmanial compound. | |||
T20660 |
Revaprazan
SB-641257,SB 641257,SB641257 |
||
Revaprazan is a novel, selective potassium-competitive acid blocker, to be specific, it reversibly inhibits gastric H(+)/K(+)-ATPase and shows effective acid suppression comparable to PPIs. | |||
T72812 |
(R)-Tegoprazan
|
||
(R)-Tegoprazan (example 3) 是一种苯并咪唑衍生物,是一种有效的胃H+/K+-ATP 酶抑制剂,对犬肾 Na+/K+-ATPase 的IC50为 98 nM。(R)-Tegoprazan 具有胃肠道疾病研究的潜力。 | |||
T36530 | Pantoprazole sulfone | ||
Pantoprazole sulfone is a metabolite of the gastric H+/K+ ATPase pump inhibitor pantoprazole . Pantoprazole is metabolized by the cytochrome P450 (CYP) isoforms CYP2C19 and CYP3A4 to form pantoprazole sulfone. | |||
T37247 |
Pantoprazole Sulfide
|
||
Pantoprazole sulfide is a metabolite of the gastric H+/K+ ATPase pump inhibitor pantoprazole . Pantoprazole is metabolized by the cytochrome P450 (CYP) isomers CYP2C19 and CYP3A4 to form pantoprazole sulfide. | |||
T28156 |
Nepaprazole
TY-11345,TY11345,TY 11345 |
||
Nepaprazole is a proton pump inhibitor. TY-11345 potently inhibited H+/K(+)-ATPase activity in isolated rabbit gastric mucosal microsomes, and the inhibitory effect was enhanced under weak acid conditions, the IC50 being 5.8 microM and 9.9 microM at pH 6. | |||
T10221L |
Abeprazan
DWP14012 |
Others | Others |
Abeprazan (DWP14012) is a potassium-competitive acid blocker and it is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases[1]. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic | |||
T61467 |
Esomeprazole magnesium salt
|
||
Esomeprazole magnesium salt is a potent and orally active proton pump inhibitor that effectively reduces acid secretion in gastric parietal cells by inhibiting the H+, K+-ATPase. This compound has shown promise for the research and treatment of symptomatic gastroesophageal reflux disease [1][2][3]. | |||
T61445 | Tenatoprazole sodium | ||
Tenatoprazole sodium (TU-199 sodium) is a potent proton pump inhibitor that effectively suppresses the activity of hog gastric H+/K+-ATPase, a vital enzymatic pump involved in acid secretion. It achieves this inhibition at an impressive IC50 value of 6.2 μM. | |||
T62316 | P-CAB agent 1 | ||
P-CAB agent 1 (compound B19) 是一种高效的钾离子竞争性酸阻滞剂,能够作用于 H+/K+-ATPase (IC50: 60.50 nM)。P-CAB agent 1 在大鼠中具表现出接受的口服吸收度。P-CAB agent 1 能够用于酸相关疾病 (ARDs) 的研究。 | |||
T61740 |
Esomeprazole hemistrontium
|
||
Esomeprazole hemistrontium, also known as (S)-Omeprazole, is a potent and orally active proton pump inhibitor that effectively reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. This compound exhibits promising potential for research in symptomatic gastroesophageal reflux disease [1] [2] [3]. | |||
T61667 |
Esomeprazole potassium salt
|
||
Esomeprazole potassium salt ((S)-Omeprazole potassium salt) is an effective and orally active proton pump inhibitor that works by inhibiting the H+, K+-ATPase enzyme in the gastric parietal cells, leading to a reduction in acid secretion. It is a promising compound for investigating symptomatic gastroesophageal reflux disease [1] [2] [3]. | |||
T78218 |
Ilaprazole sodium hydrate
IY-81149 sodium hydrate |
Proton pump | Membrane transporter/Ion channel |
Ilaprazole (IY-81149) sodium hydrate是一种具有口服活性的质子泵抑制剂,可以量依赖性地不可逆抑制H+/K+-ATPase,并在兔壁细胞制剂中展示出IC50为6μM的效力。该化合物主要用于胃溃疡的研究,并已证实是一种有效的T细胞起源蛋白激酶(TOPK)抑制剂。 | |||
T37659 |
5-hydroxy Omeprazole
|
||
5-hydroxy Omeprazole is a major metabolite of omeprazole , an inhibitor of the gastric H+/K+-ATPase pump.[1] 5-hydroxy Omeprazole is produced from omeprazole by the action of cytochrome P450 (CYP) isoform 2C19, a monooxygenase. [2][3] CYP2C19 polymorphisms significantly influence the metabolism of omeprazole, and individuals may be classified as homozygous extensive metabolizers, heterozygous extensive metabolizers, and poor metabolizers.[1] |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0184 |
Chebulinic acid
|
ATPase; Proton pump; DNA/RNA Synthesis; Antibacterial; TGF-beta/Smad | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Membrane transporter/Ion channel; Microbiology/Virology; Stem Cells |
Chebulinic acid 是从诃子果中提取的一种天然产物,结核分枝杆菌 DNA 促旋酶的有效抑制剂。它也能抑制 SMAD-3 phosphorylation 和 H+ K+-ATPase 的活性。 | |||
TN4697 |
Odoroside H
|
ATPase; Potassium Channel; Sodium Channel | Membrane transporter/Ion channel |
Odoroside H has anticancer activities, the cytotoxic effects are induced by the inhibition of the plasma membrane bound Na(+)/K(+)-ATPase. | |||
T38069 |
Aquastatin A
|
||
Aquastatin A is a fungal metabolite originally isolated fromF. aquaeductuumthat has diverse biological activities.1It is active againstS. aureus(MIC = 32 μg/ml) and inhibits enoyl-acyl carrier protein reductase (Fabl; IC50= 3.2 μM) andS. aureusfatty acid synthesis (IC50= 3.5 μM).2Aquastatin A also inhibits the Na+/K+-ATPase and H+/K+-ATPase (IC50s = 7.1 and 6.2 μM, respectively), as well as protein tyrosine phosphatase 1B (PTP1B; IC50= 0.19 μM).1,3 1.Hamano, K., Kinoshita-Okami, M., Minagawa, K.... |